Alyeska Investment Group’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,662
| Closed | -$465K | – | 560 |
|
|
2024
Q3 | $465K | Sell |
21,662
-27,172
| -56% | -$583K | ﹤0.01% | 489 |
|
|
2024
Q2 | $1.11M | Buy |
+48,834
| New | +$1.11M | 0.01% | 432 |
|
|
2017
Q3 | – | Sell |
-1,466
| Closed | -$743K | – | 437 |
|
|
2017
Q2 | $743K | Sell |
1,466
-2,284
| -61% | -$1.16M | 0.01% | 400 |
|
|
2017
Q1 | $2.16M | Buy |
3,750
+2,679
| +250% | +$1.54M | 0.02% | 383 |
|
|
2016
Q4 | $591K | Buy |
1,071
+9
| +0.8% | +$4.97K | ﹤0.01% | 424 |
|
|
2016
Q3 | $733K | Buy |
1,062
+42
| +4% | +$29K | 0.01% | 410 |
|
|
2016
Q2 | $490K | Buy |
1,020
+21
| +2% | +$10.1K | ﹤0.01% | 396 |
|
|
2016
Q1 | $612K | Buy |
999
+258
| +35% | +$158K | 0.01% | 357 |
|
|
2015
Q4 | $578K | Sell |
741
-578
| -44% | -$451K | 0.01% | 344 |
|
|
2015
Q3 | $1.21M | Buy |
1,319
+92
| +7% | +$84.5K | 0.01% | 367 |
|
|
2015
Q2 | $1.96M | Sell |
1,227
-23
| -2% | -$36.7K | 0.02% | 333 |
|
|
2015
Q1 | $1.58M | Buy |
+1,250
| New | +$1.58M | 0.02% | 369 |
|